About TB-500 Pharmacy
A medicine is usually something added. The experiments that make that instinct unreliable are the ones worth explaining.
The active ingredient
A pharmacy brings to mind an active ingredient prepared for a purpose. The liver studies make that ordinary picture surprisingly difficult. In mice with thymosin beta-4 deleted from hepatic stellate cells, fibrosis improved. In another rodent experiment, supplying the full protein also improved fibrosis.
An explanation accounting for both findings would be more satisfying than either paper taken alone. Choosing whichever experiment sounds most useful would leave the interesting problem untouched. These were different interventions, and the difference may matter more than the shared name of the protein.
That is the question behind TB-500 Pharmacy: how far can an active ingredient’s reputation travel before it loses the cells and circumstances that produced the result? The studies concern full-length thymosin beta-4. Extending them to the short TB-500 fragment introduces another unresolved step.
The TB-500 Pharmacy name
TB-500 Pharmacy names this collection of essays; there is no dispensing business behind it. No clinical consultation or prescription is available through me or through these pages. There is no stock to order, parcel service or appointment calendar here.
The subject is published medical research, but these essays cannot serve as medical advice for an individual. A person’s health, existing treatment and particular circumstances require a qualified clinician’s assessment. An interest in experimental biology gives me no authority to make that assessment.
Cell-specific effects
I’d investigate which cells produce thymosin beta-4 and the stage of injury at which they produce it. The targeted-deletion experiment makes that specificity worth pursuing. I don’t think the opposing liver interventions can be reconciled by repeating that the protein helps repair.
Other experiments make neat conclusions difficult in their own ways. The muscle-function study found more regenerating fibers without a significant strength gain. I’d call that an important limit on the adjective “regenerative.” Likewise, the rat stroke dose response frustrates a simple assumption that more exposure yields more benefit. An experimental result earns its interest from the exact thing that happened.